title: The Effect of D-Tagatose on Fructose Absorption in a Rat Model.
abstract: D-tagatose is in development as a medication for the treatment of type 2 diabetes. The effect of oral D-tagatose on the absorption of D-fructose was assessed when co-administered in this study. In the pilot study, male Sprague-Dawley rats were fed C14 labeled fructose and glucose concomitantly to establish dose levels for the treatment group of rats fed C14 labeled fructose together with D-tagatose. Rats were administered 0, 600, 2000, 6000, or 12000 mg/kg of D-tagatose along with 2000 mg/kg of fructose. Blood samples were taken over 60 minutes and were assessed using scintillation counting. 600, 2000, and 6000 mg/kg of D-tagatose decreased fructose absorption by 1%, 26%, and 30% respectively (12000 mg/kg group was stopped short of completion due to intolerance) as measured by AUC of scintillation counts. The 600 and 2000 mg/kg of D-tagatose groups showed no difference in plasma glucose concentrations compared to placebo while a rise in glucose was seen in the 6000 mg/kg of D-tagatose groups. The results indicate that D-tagatose may be useful in reducing fructose absorption, which could lead to a beneficial outcome.
authors.affiliation: Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, USA.
authors.forename: Jarrod
authors.initials: J
authors.lastname: Williams
authors.affiliation: Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Spitnale
authors.affiliation: Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Lodder
keywords: D-tagatose; Diabetic medication; Fructose; Oral absorption; Oral gavage